Biotechnology News

LONDON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Engitix Ltd., a biotechnology company pioneering extracellular matrix (ECM)-based drug discovery and development in oncology, fibrosis and...

Sapreme Therapeutics announces its lead Duchenne muscular dystrophy candidate, SPM-2551, and is presenting preclinical data at the OTS Annual Meeting.

TRexBio Announces Closing of Initial Public Offering

Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multispecific drug candidates with tailored biological functions ...

Mechelen, Belgium; October 13, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ:...

Mechelen, België; 13 oktober 2026, 22.01 CET; gereglementeerde informatie In het kader van het op 9 juni 2026 aangekondigde inkoopprogramma maakt Lakefront Biotherapeutics NV (Euronext & NASDAQ:...

SANGAMO THERAPEUTICS LAUNCHES AUCTION PROCESS FOR CLINICAL-STAGE CHRONIC NEUROPATHIC PAIN PROGRAM

The Elite Graft Program combines advanced biologic wound care, reimbursement support, and clawback protection to build provider confidence.

Giraffe Bio raises $6.4M to scale drop-in biochemical flotation reagents that help mines recover more copper without requiring new equipment.

PROTEXT MOBILITY CHAIRMAN CONFIRMS 831.3 MILLION COMMON SHARES IN SEC FILING - CHAIRMAN AND CEO REAFFIRM ZERO PREFERRED CONVERSIONS